{
  "retracted": false,
  "timestamp": 1490054400000,
  "updates": [
    {
      "timestamp": 1550365864114,
      "identifier": {
        "doi": "10.1161/cir.0000000000000495"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1161/circulationaha.116.025783"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"
}
